Rallybio Corp short interest in 2021

In 2021, Rallybio Corp's disclosed short interest ran from 1.14% of shares outstanding on 15 Oct 2021 to 1.49% on 31 Dec 2021, a change of +0.35 percentage points. The year's high was 1.49% on 31 Dec 2021 and its low 1.14% on 15 Oct 2021, averaging 1.31% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.57 days on 15 Dec 2021. Full history: Rallybio Corp.

Cite this page

Plain

Short position data for Rallybio Corp short interest in 2021: FINRA, compiled by howshorted.com, settlement date 31 Dec 2021. https://howshorted.com/us/company/rlyb/2021/

Wikipedia

<ref>{{cite web |title=Rallybio Corp short interest in 2021 short position data |url=https://howshorted.com/us/company/rlyb/2021/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2021-12-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-rallybio-corp-short-interest-in-2021-2021-12-31,
  title        = {Rallybio Corp short interest in 2021 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/rlyb/2021/}},
  note         = {Data: FINRA, settlement date 31 Dec 2021; accessed 2026-10-13},
  year         = {2021}
}

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2021 in figures

Start of year: 1.14% (15 Oct 2021)
End of year: 1.49% (31 Dec 2021)
Change: +0.35 pp
High: 1.49% (31 Dec 2021)
Low: 1.14% (15 Oct 2021)
Average: 1.31%
Highest days to cover: 16.57 (15 Dec 2021)
SEC filings marked: 4

Every report in 2021

Rallybio Corp short interest in 2021
Settlement	Short interest	Days to cover	Filings since previous
15 Oct 2021	1.14%	4.79	10-Q filed, results (8-K)
29 Oct 2021	1.42%	9.46
15 Nov 2021	1.27%	8.15	10-Q filed, results (8-K)
30 Nov 2021	1.23%	15.90
15 Dec 2021	1.33%	16.57
31 Dec 2021	1.49%	5.01

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.